New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Penn West Petroleum Ltd (USA) (NYSE:PWE), Dot Hill Systems Corp (NASDAQ:HILL), IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI), Inovio Pharmaceuticals Inc (NYSEMKT:INO)
Penn West Petroleum Ltd (USA) (NYSE:PWE) showed a volume of 3.12 million shares by the end of last trade whereas the average volume of the stock remained 2.39 million shares. The stock opened the session at $8.65 but then moved to $8.34. At that price, the stock showed a negative performance of -4.14%. Penn West Petroleum Ltd. (Penn West), formerly Penn West Energy Trust, is a Canadian exploration and production company. Penn West is engaged in the business of acquiring, exploring, developing, exploiting and holding interests in petroleum and natural gas properties and related assets. Penn West participates in the exploration for, and the development and production of,
Will PWE Get Buyers Even After The Recent Rally? Find Out Here
Dot Hill Systems Corp (NASDAQ:HILL) opened the session at $3.46 and closed the session at $4.00. The stock showed a positive performance of 15.27% in previous trading session. Dot Hill Systems Corp. (Dot Hill) is engaged in designing, manufacturing and marketing a range of software and hardware storage systems for the entry and mid-range storage markets. The Company operates in two segments: storage systems and standalone storage software. The Company's storage solutions consist of integrated hardware, firmware and software products employing a modular system that allows end-users to add various protocol,
For How Long HILL will fight for Profitability? Read This Trend Analysis report
IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) opened the session at $3.52 and closed the session at $3.68. The stock showed a positive performance of 5.75% in previous trading session. The beta of the stock remained 1.23. Intellipharmaceutics International Inc. (IPC) is a pharmaceutical company specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technologies are a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a range of existing and new pharmaceuticals.
Why Should Investors Buy IPCI After The Recent Gain? Just Go Here and Find Out
Inovio Pharmaceuticals Inc (NYSEMKT:INO) the stock decreased -0.81% and finished the session at $24.6. Traded with volume of 3.03 million shares in the prior session and the average volume of the stock remained 5.20 million shares. The beta of the stock remained 3.26. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
Will INO Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)